-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Anavex Life Sciences Corp. quarterly Deferred Tax Assets, Gross history and change rate from Q3 2023 to Q3 2025.
- Anavex Life Sciences Corp. Deferred Tax Assets, Gross for the quarter ending September 30, 2025 was $20.7M, a 37.1% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)